1 / 1

Acute and Late Toxicity of Chemotherapy-Enhanced Radiation Therapy in Head and Neck Oncology

This study explores the comparative acute and late toxicity levels of chemotherapy-enhanced radiation therapy versus altered fractionation in head and neck cancer treatment. By analyzing endpoints with higher toxicity, the research aims to delineate the safety profiles of both treatment approaches. The findings contribute to optimizing radiotherapy fractionation and concurrent chemotherapy, marking a significant advance in head and neck oncology. This work underscores the critical balance between treatment efficacy and minimizing adverse effects for patients undergoing these therapies.

ira-washington
Télécharger la présentation

Acute and Late Toxicity of Chemotherapy-Enhanced Radiation Therapy in Head and Neck Oncology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 4 Acute and late toxicity: endpoints with higher toxicity in the chemotherapy-enhanced radiation therapy-altered fractionation arm compared with the altered fractionation arm Bernier J (2005) Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology? Nat Clin Pract Oncol 2 305–314 10.1038/ncponc0201

More Related